Juan Pablo Kaski

From @gabycaptur+ @jpkaski+ team: A Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children with HCM ahajournals.org/doi/10.1161/CI… @AHAScience #AHAjournals #CardioTwitter #Genetics @Prof_K_Mills @UCL_ICS @GreatOrmondSt 📽️ @hj_tadros

ESC TV Today: @jpkaski ´s concise summary of gene testing in dilated CMP - gene variants are identified in 30-40% of cases, w/ consequences for risk stratification, family screening, response to meds and more esc365.escardio.org/event/1153 (start at 06:57) @escardio #cardiotwitter

A new blood test that could identify children with a potentially fatal heart condition known as hypertrophic cardiomyopathy has been developed by Prof Juan Pablo Kaski @jpkaski and team @UCL_ICS @UCLchildhealth @GreatOrmondSt @lifearc1 @actionmedres ucl.ac.uk/news/2024/jun/…

Up to 1000 children in the UK live with hypertrophic cardiomyopathy (HCM), the leading cause of sudden death in children and teenagers. #Research from GOSH and @UCLchildhealth, funded by @lifearc1, means a blood test could now diagnose the condition. gosh.nhs.uk/news/new-blood…

🫀Just out @Circ_Gen 👉our HCM plasma proteomics assay identifies children at ⬆️ risk of sudden death @jpkaski 🌟 @Prof_K_Mills 🌠 @UCL_ICS 💫 Thank you to all the children @GreatOrmondSt 🤩 ahajournals.org/doi/10.1161/CI…

New tech helps prevent children from sudden cardiac death channel4.com/news/new-tech-…

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. Read more in #EHJ @escardio @ESC_Journals #CardioTwitter academic.oup.com/eurheartj/adva…

Danon disease is a rare X-linked myopathy associated with severe #heartfailure. This #JACC state-of-the-art review highlights the pathophysiology, diagnosis, & management of this important disease process: bit.ly/3rIbm2F @EricAdler17 #CardioTwitter

Officially now out in @ESC_Journals @ehj_ed - 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC) #CardioTwitter #genechat academic.oup.com/eurheartj/arti…

Upcoming @escardio webinars discussing 🆕 #cardiomyopathies guidelines with members of the Task Force! 🆓 registration for #ESC professional members! Register now esc365.escardio.org/event/1062?utm… @jpkaski @dr_pavia @ProtonotariosA @RJurcut @arbelo_e @SilCastelletti @ImazioMassimo

Juan Pablo Kaski talks about some of the highlights of the ESC guidelines on cardiomyopathies with regard to the phenotype-specific management of cardiomyopathies. Watch: pace-cme.org/2023/09/11/fir… #Cardiomiopathy #ESCcongress #Cardiotwitter

🎥 Interview with @jpkaski, about the brand new #ESCGuidelines for the Management of #Cardiomyopathies. -> medicaldigest.org/scientific-con… #ESCCongress @ESCardio @ESCardioNews #cardiology #CardioTwitter

!!#ESC Cardio Genomics 2023: registration & call for abstracts now open!! #ESCgenomics #MedTwitter 👉Join us in Naples, 21 – 22 October 2023. ☝️Open to every HCP in link with genomic medicine, and researchers esc365.escardio.org/event/1089

A new set of guidelines for the clinical management of cardiomyopathy has been published today. The guidelines are intended to assist healthcare providers in clinical decision-making, and set out the recommended aspects of cardiomyopathy treatment. 📲 cardiomyopathy.org/news-blogs/lat…

A huge shoutout to our @escardio Cardiomyopathy Guidelines co-chairs @jpkaski @arbelo_e who considered genetic counselling an important enough addition to warrant an author and a section in the doc💥 #ESCCongress /1 escardio.org/Guidelines/Cli…

Wonderful to see so many friends and colleagues @escardio Congress in Amsterdam. Honoured to have chaired and presented the 1st international guidelines on #cardiomyopathies with @arbelo_e. Thank you to all the taskforce members - a great team of experts & real team effort!

NEW: 2023 #ESCGuidelines for the management of #cardiomyopathies 👉escardio.org/Guidelines/Cli… #ESCCongress

Another full room for the 2023 ESC Guidelines for Management of Cardiomyopathies - discussion of the guidelines in practice! #ESCCongress

The first set of #ESCGuidelines for cardiomyopathy. Fantastic to see standing room only at #ESCCongress2023 as guidelines aim to increase CM awareness outside the subspecialty #CardioGen clinic academic.oup.com/eurheartj/adva…

2023 ESC Guidelines for the management of cardiomyopathies! @escardio @ESC_Journals academic.oup.com/eurheartj/adva…